Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,580.06
(
0.22%
)
US TECH 100
29,522.00
(
0.33%
)
Dow Jones
51,032.46
(
0.72%
)
Brent Oil
91.36
(
0.00%
)
Bitcoin
73,598.44
(
0.31%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

freethemice

Send PM Follow Ignore
Followers 50
Posts 1681
Boards Moderated 0
Alias Born 02/15/2007

freethemice

Re: cjgaddy post# 90257

Thursday, 09/06/2012 10:38:15 AM

Thursday, September 06, 2012 10:38:15 AM

Post# of 347009
The 5.4 months for the control arm also tells us that this patient group was pretty sick. King has said that
over 90% were stage 4 (metastatic disease). If you look back at my table for the second-line NSCLC phase 3 trials,
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=77206110
you can see that 5.4 months is less than all of them. That makes the current situation all the more remarkable.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote